The BHARAT study: a multi-modal, multi-omics investigation of aging signatures in the Indian population

May 4, 2026Aging

The BHARAT study: combining multiple tests to identify aging markers in Indian people

AI simplified

Longevity & Aging on OpenScience ↗PubMed ↗DOI ↗

Abstract

India's elderly population is projected to exceed 347 million by 2050.

Aging is a primary risk factor for multiple chronic diseases, yet existing biological age models are largely based on Western populations.
The BHARAT study aims to create and validate aging signatures specific to the Indian demographic by combining various types of biological and lifestyle data.
Participants are grouped into five age categories, ensuring a balanced representation of rural and urban populations as well as genders.
The study focuses on healthy individuals, excluding those with unresolved chronic diseases, to gather comprehensive health data.
Multi-omics profiling will include various biological analyses, contributing to the development of context-specific aging biomarkers.
As the first major aging study in India, BHARAT could facilitate the creation of reference datasets and frameworks for future aging research.

AI simplified

India is undergoing a rapid demographic transition, with its elderly population projected to exceed 347 million by 2050. Although aging is the primary risk factor for multiple chronic diseases, most biological age (BA) models have been developed for Western populations, with limited applicability to Indian demographics. The BHARAT study (Biomarkers of Healthy Aging, Resilience, Adversity, and Transitions) aims to develop and validate composite signatures of aging in the Indian population by integrating multi-omics, biochemical, clinical, and lifestyle data. The BHARAT study is a multi-center, cross-sectional observational study designed using a hub-and-spoke model, with the Indian Institute of Science (IISc) serving as the central hub for omics analyses, biobanking, and data integration. Participants are stratified into five age groups (18-29, 30-44, 45-59, 60-74, ≥75 years) with balanced rural-urban and gender representation. The study primarily includes healthy participants, excluding those with chronic diseases that are not resolved by medication. Data collection encompasses comprehensive clinical and cognitive assessments, lifestyle and quality-of-life questionnaires, and biological sampling (including blood, urine, stool, cheek swabs, and hair). Multi-omics profiling spans epigenomics, proteomics, metabolomics, lipidomics, metagenomics, and immune phenotyping, integrating untargeted discovery-based Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) with targeted assays under harmonized protocols and quality-controlled biobanking standards. As the first large-scale, discovery-driven aging cohort in India, BHARAT will generate population-specific reference datasets, (re)train and calibrate biological clocks, develop a data-driven framework for organ-specific clocks, and identify biomarkers of physiological resilience and decline. Given that presently this study is cross-sectional in design, it will help establish a scalable framework for subsequent longitudinal and translational research to develop context-specific diagnostics, predictive models, and therapeutic targets for healthy aging in India.

Full Text

Full text is available at the source.

View full text ↗

Featured in

Longevity & AgingIssue #36

A supplement increased retinal thickness in diabetic patients over 24 weeks

↗

The BHARAT study: a multi-modal, multi-omics investigation of aging signatures in the Indian population

Abstract

Full Text

Featured in

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the longevity & aging brief